Extended Release Naltrexone (Vivitrol®)

The U.S. Food and Drug Administration (FDA) has approved three medications for use in treating opioid dependence: methadone, buprenorphine, and naltrexone. Extended release naltrexone, brand name Vivitrol®, is a once-monthly injection intended to help prevent relapse to opioid use. Read this fact sheet for more information on naltrexone.
Drug Replacement and Maintenance Therapy
Fact Sheet